Trial Profile
Efficacy of vildagliptin monotherapy on glycemic control in type 2 diabetic patients on hemodialysis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 17 Mar 2011 New trial record